Pertussis is a rare condition in adults. This report describes a 65-year-old man presenting to the otolaryngology service with hoarseness secondary to pertussis. He had a history of worsening cough and hoarseness occurring over several weeks. Laryngoscopy showed significant erythema at the medial edges of the vocal folds. Stroboscopy demonstrated bilateral decreased amplitude and decreased mucosal wave of the vocal folds. Polymerase chain reaction testing of the sputum revealed Bordetella pertussis. The patient was started on azithromycin, and he reported gradual resolution of the chest and laryngeal symptoms over the next few months. Pertussis, or whooping cough, is not common in the United States because of childhood vaccination protocols. Nevertheless, otolaryngologists need to be aware of this condition as a possible cause of hoarseness.
Introduction
Pertussis, or whooping cough, is an acute respiratory infection caused by the gram-negative coccobacillus Bordetella pertussis. This disease is transmitted from person to person through large respiratory droplets produced by coughing or sneezing. Pertussis remains endemic in the United States despite routine childhood vaccination programs. 1 Immunity from pertussis wanes approximately 5 to 10 years after the childhood vaccinations are completed. 2 Since the 1980s, the number of reported pertussis cases has steadily increased; this increase is most notable in adults (figure 1). Because of the chronic cough associated with this condition, significant voice disturbances can occur. Otolaryngologists need to be aware of this condition as a possible cause of adult hoarseness.
We present a case of an adult who presented to the otolaryngology clinic with hoarseness and was subsequently diagnosed with pertussis. He was treated with antibiotics, and his voice symptoms resolved.
Case report
A 65-year-old man was referred to the otolaryngology clinic for evaluation of hoarseness. Three weeks earlier, the patient reported the onset of cough, nasal congestion with discharge, fever, and headache. He was seen by his primary care physician and diagnosed with a viral upper respiratory tract infection. Over the next few days, his nasal symptoms improved, but the cough and hoarseness persisted. A chest radiograph at the time was normal. No other initial studies were ordered.
At the initial otolaryngology visit, the patient was noted to have a raspy voice with a cough productive of thick sputum. The patient is a physician working as an epidemiologist. He felt that his cough had developed into a paroxysmal cough over the previous few days, and he had started himself on azithromycin for possible pertussis. At the time of this visit, he was on his third day of a 5-day course of azithromycin (500 mg orally for the first day, 250 mg orally for the next 4 days).
On physical examination the patient's vocal folds were noted to be mobile, but significant erythema was present at the medial edges (figure 2, A). Stroboscopy demonstrated bilateral decreased amplitude and decreased mucosal wave. This generalized erythema of the vocal folds was consistent with the patient's history of persistent cough. His sputum was sent for a pertussis polymerase chain reaction (PCR) assay.
The patient was started on a 10-day prednisone taper (60 mg for 4 days, 30 mg for 4 days, and 10 mg for 2 days). The patient noted considerable improvement after the course of azithromycin. Over the next 4 weeks, the patient was seen regularly, and significant improvement in his voice and vocal fold exam was noted. His PCR test proved positive for pertussis. He did not recall any Volume 91, Number 2 www.entjournal.com  E23 Pertussis Presenting as hoarseness in an adult sis is usually not as severe in adults as in children, it can be difficult to diagnose. This can lead to exposure to newborns, unvaccinated children, and adult healthcare workers.
B pertussis is a fastidious, aerobic, gram-negative coccobacillus. 3, 8 It spreads via airborne respiratory droplets and can live outside a host in these secretions for a few hours. 3, 5, 8 Pertussis colonizes the ciliated upper respiratory epithelia of its host, where it suppresses ciliary motility and begins producing many cytotoxins. 3, 8 Pertussis toxin causes lymphocytosis, histamine sensitization, and insulin production, leading to hypoglycemia. 3 The causative organism is not invasive and does not penetrate the submucosa or enter the bloodstream. 3, 8 Pertussis spreads readily and is quite contagious because of its preferred location in the upper respiratory tract, allowing it easy access to expiratory secretions.
Pertussis in small children usually presents with cough-obvious exposure at home or work. He had received his childhood pertussis immunizations but had not had any pertussis booster shots. Three months after his initial presentation, the patient reported complete resolution of symptoms. Laryngoscopy demonstrated significant improvement ( figure 2, B ).
Discussion
Whooping cough has afflicted human society for centuries. At the beginning of the nineteenth century, pertussis killed more children than any other single infection in the United States. 3 It acquired its colloquial name from the whooping inspiratory sounds that children would make after bouts of long coughing spells. Traditionally, this disease has been affiliated with childhood infection and infant mortality, but recently it has been emerging in vaccinated adults. [4] [5] [6] [7] [8] [9] Recently, California has had a resurgence of this disease. In 2010, there were 9,143 cases in California; this was the highest number of reported cases since 1947, when 9,394 cases were reported. 10 Of the 2010 cases, 805 (9%) resulted in hospitalization, and 10 deaths were reported; the majority of these hospitalized patients (72%) were infants less than 6 months of age. 10 This outbreak is possibly due to declining vaccination rates, especially in the adolescent population. 11 In the United States, pertussis vaccination of the general pediatric population has occurred since the 1940s. 5 Evidence indicates that adult immunity to this disease wanes with age. [5] [6] [7] [8] Adults with pertussis have been recognized in increasing numbers over the past 20 years. 5 In 2004, there were 25,827 cases reported to the Centers for Disease Control and Prevention (CDC), with 7,008 (27%) of them occurring in the 19-to 64-year-old age group. 5 Worldwide, pertussis is still a major cause of morbidity and mortality, with approximately 51 million cases and 600,000 deaths annually. 3 Since pertus- ing fits followed by high-pitched inspiratory sounds (whoops). There are three phases of disease progression: catarrhal, paroxysmal, and convalescent. The catarrhal phase lasts about 2 weeks and usually presents with fever, followed by myalgias and other flu-like symptoms. In the 2-to 4-week paroxysmal phase, exacerbations of cough may cause cyanosis. Shortness of breath, tachypnea, and post-tussive emesis are also common. The convalescent phase is the recovery period, with decreasing coughing spells and resolution of respiratory symptoms. 3, 5, 8 Adults with pertussis usually present with milder upper respiratory symptoms, making the diagnosis difficult. 3, 5, 6 Symptoms are less severe than in children and can be subclinical. 6, 8 The disease most commonly presents with a prolonged, distressing cough that can last more than 9 weeks in some cases. 5 Adults will occasionally report sweating attacks, an uncommon finding in children. 8 Sputum culture is frequently used in children for diagnosis. However, cultures are frequently negative in adults. 8 Direct fluorescent antibody testing is commonly used during outbreaks, but it has many drawbacks, including low specificity. 3, 8 Antibody testing is not good for identifying an active infection in U.S. adults because most of them have already received the vaccine. PCR testing of the sputum is the most sensitive and specific diagnostic test for both children and adults. 8 The most common treatment regimen in adults is administration of a macrolide antibiotic. Variations in the length of treatment are common. Although our patient was placed on steroids, a recent Cochrane review did not show any significant reduction in cough in patients treated with steroids. 12 Treatment of pertussis with steroids remains controversial.
Diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine is a live attenuated vaccine provided to every infant in the United States before the age of 2 years. 3, 7, 9 Currently, the CDC and the Advisory Committee on Immunization Practices recommend starting acellular DTaP vaccinations for all adolescents and adults. 4 Adolescents should receive a single booster at 11 or 12 years of age, and adults 19 to 64 years old are now advised to receive a single dose of DTaP. 4, 5 With the recent outbreak of pertussis in California, increased attention has been directed toward the vaccination of healthcare providers. The California Department of Public Health (CDPH) recommends that all healthcare personnel, particularly those who have direct contact with infants and pregnant women, be immunized with DTaP to protect their patients and themselves. 13 Patients commonly present to the otolaryngologist with hoarseness and cough. Our patient presented with significant hoarseness. Because pertussis rates have recently been increasing, it is important to consider the possibility of this disease in a patient with chronic cough and hoarseness, as a delay in diagnosis places both the patient and surrounding contacts at risk.
